Manufacturing And Sustainability
-
The Role of Peptones In Enhancing Efficiency
9/30/2024
Discover how peptones enhance vaccine manufacturing efficiency with valuable insights into cost-effective solutions, variability control in biologically derived materials, and more.
-
Cytovance Customer Testimonial: Thermo Scientific Single-Use Technologies
12/8/2020
Thermo Fisher Scientific has served as a key partner in the bioprocess industry, by establishing manufacturing and development capabilities, enabling Cytovance Biologics to expand offerings their product offering, to better serve clients with diverse pharmaceutical needs. In this video, the imPULSE Single-Use Mixer is highlighted for protein refolding applications at a 30 L scale and then transferred to manufacturing operations up to 5,000 L scale.
-
The Role Of Peptones In Boosting Quality And Yield
11/4/2024
Peptones can significantly boost CHO cell bioprocessing. We analyze their impact on diverse CHO cell lines using real-world data to assess their effects on titer, protein quality, and cell growth.
-
Thermo Fisher Scientific Single-Use Global Manufacturing Network
4/18/2022
We have implemented a multi-tier strategy to improve the resiliency of our supply chain and created the largest networked single-use manufacturing organization in the world.
-
An Innovative Approach To High Aggregate Challenges
7/14/2025
In this webinar, hear from a technical specialist on addressing the challenges with antibody aggregates and process related impurity removal using a new high performance chromatography resins
-
Interview With Nico Chow And Sandi True, Field Applications Specialists
11/6/2025
Hear Nico Chow and Sandi True, Field Applications Specialists, discuss working with customers to help them evaluate and implement Residual DNA Quantitation, Mycoplasma Detection, and Microbial Identification Assays.
-
Addressing Post-Translational Modifications In Novel Protein Therapeutics
9/13/2024
Meinhard Hasslacher, Ph.D., Head of CMC at SOTIO Biotech, addresses an audience question on conjugation efficiencies in this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics. From there, we move on to an audience-led discussion on when to initially address titer, PTMS, and product quality during development of novel protein therapeutic cell lines, with Lena Tholen, Ph.D, Director of Cell Line and Bioprocess Development at FyoniBio and Neeraj Pakala, Ph.D. SVP of Product Development and Manufacturing at Vera Therapeutics weighing in.
-
Digital Solutions For Accelerated Innovation
5/19/2025
In this webinar, hear how Applied Biosystems AccuSEQ software serves as an advanced digital tool that can help streamline bioanalytical processes and accelerate the delivery of life-changing therapies.
-
Thermo Fisher Scientific Suzhou, China Manufacturing Site Capabilities
11/2/2018
Watch this video to learn more about this manufacturing site capabilities, quality management systems, PPI implementation, product expansion, assurance of supply and lead times.
-
The Impact Of The Clinical Hold
2/21/2023
In this segment of the Bioprocess Online Live event IND Success: Navigate Through The Regulatory Gray, Umoja Biopharma VP of Regulatory Affairs Helen Kim and NDA Partners Regulatory Affairs Expert Consultant Daniela Drago, Ph.D. discuss the ramifications of a clinical hold on your study progress, investor perception, and timelines.